AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Heidelberg Pharma AG

Declaration of Voting Results & Voting Rights Announcements Aug 12, 2010

201_dva_2010-08-12_a14d7c69-51c7-49ca-9dc3-dd52e4261e77.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

News Details

Voting Rights Announcements | 12 August 2010 16:30

WILEX AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

WILEX AG / Release of an announcement according to Article 21, Section 1 of the WpHG [the German Securities Trading Act] (share)

12.08.2010 16:30

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.


On August 10, 2010, WestLB, Düsseldorf, Deutschland has informed us
according to Article 21, Section 1 of the WpHG that via shares its Voting
Rights on WILEX AG, Munich, Germany, ISIN: DE0006614720, have exceeded the
3%, 5% and 10% limit of the Voting Rights on August 05, 2010 and on that
day amounted to 13.81% (this corresponds to 2542000 Voting Rights).

On August 10, 2010, WestLB, Düsseldorf, Deutschland has informed us
according to Article 21, Section 1 of the WpHG that via shares its Voting
Rights on WILEX AG, Munich, Germany, ISIN: DE0006614720, have fallen below
the 10%, 5% and 3% limit of the Voting Rights on August 09, 2010 and on
that day amounted to 0.00% (this corresponds to 0 Voting Rights).

12.08.2010 Ad hoc announcement, Financial News and Press Release distributed by DGAP.
Media archive at www.dgap-medientreff.de and www.dgap.de


Language: English
Company: WILEX AG
Grillparzerstr. 10
81675 München
Deutschland
Internet: www.wilex.com

End of News DGAP News-Service


Talk to a Data Expert

Have a question? We'll get back to you promptly.